SB-001 (AcadeMab Biomedical)

N/A

Report date: 2023/10/16 13:53:49

Base Information

Drug NameSB-001 (AcadeMab Biomedical)
Drug Alias NamehAbs SB-01
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionVirus internalization inhibitorsSARS-CoV-2 Spike glycoprotein receptor binding domain modulators
TargetsSARS-CoV-2 Spike glycoprotein receptor binding domain
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAcadeMab Biomedical Inc
China Registration ClassN/A

Develop Information

Active CompaniesAcadeMab Biomedical Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A